Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
185 participants
INTERVENTIONAL
2016-12-08
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Traditional Chinese Medicine Sequential Treatment for Endometriosis Associated Infertility
NCT02676713
A Survey on Efficacy and Safety in Patients With Endometriosis
NCT02921763
Acupuncture for Pain of Endometriosis
NCT03125304
Efficacy of Double Contrast-enhanced Ultrasound of Pelvic in Preoperative Evaluation of Deep Endometriosis
NCT05540821
The Effect of Endometrial Scratching on Patients With Endometriosis
NCT05360875
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
green tea group
green tea extract SUNPHENON EGCg for women with ultrasound confirmed endometriosis
SUNPHENON EGCg
SUNPHENON EGCg Oral, 400mg, twice per day
placebo group
placebo fro women with ultrasound confirmed endometriosis
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SUNPHENON EGCg
SUNPHENON EGCg Oral, 400mg, twice per day
Placebo
Placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Verbal pain rating scale \> 4/10 and visual analogue pain scale \> 4cm; and
* Ultrasound confirmed endometrioma with or without fibroid and adenomyoma; and
* Planned surgery treatment within 4-6 months
Exclusion Criteria
* BMI \<18.5 kg/m2 as underweight or \>25 kg/m2 as overweight; or
* Chronic pelvic pain or low back pain due to other medical conditions, e.g. urological disorders and orthopaedic disorders; or
* Secondary dysmenorrhoea due to gynaecological conditions other than endometriosis, e.g. pelvic inflammatory diseases, genitourinary infections, gynaecological tumours, etc.; or
* Primary dysmenorrhoea without any underlying disease identified; or
* Ultrasound suggested polycystic ovary, haemorrhagic ovarian cyst, ovarian dermoid cyst, cystic neoplasm, tubo-ovarian abscess or other ovarian pathologies in the same ovary; or
* Chronic medical conditions under long-term medications; or
* Endometriosis under active medication in past 1 month; or
* History of herbal medicine intake in past 1 month
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Sun Yat-sen University
OTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
Jiangxi University of Traditional Chinese Medicine
OTHER
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronald Wang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald Wang, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prince of Wales Hospital
Shatin, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6904267
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.